Bulletin
Investor Alert

Advaxis Inc.

OTC: ADXS

GO
/marketstate/country/us

Market closed

/zigman2/quotes/200910068/composite

$

0.07

Change

+0.0031 +4.78%

Volume

Volume 950,200

May 20, 2022, 3:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200910068/composite

Previous close

$ 0.06

$ 0.07

Change

+0.0031 +4.78%

Day low

Day high

$0.06

$0.07

Open
Open: 0.06

52 week low

52 week high

$0.06

$0.71

Open

Market cap

$9.45M

Average volume

452,820

P/E ratio

N/A

Rev. per Employee

$108,333

EPS

-0.10

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/adxs

MarketWatch News on ADXS

  1. Advaxis stock price target cut to $2.25 from $5.00 at Alliance Global

    7:26 a.m. April 19, 2021

    - Tomi Kilgore

  2. 5 things to know about Hookipa Pharma ahead of its IPO

    7:26 a.m. April 18, 2019

    - Sarah Toy

  3. Advaxis shares rise 68% premarket after FDA lifts clinical hold on its drug

    8:09 a.m. July 13, 2018

    - Emma Court

  4. Advaxis shares drop as cancer-drug study on hold after death

    5:19 p.m. March 12, 2018

    - Wallace Witkowski

  5. Cancer vaccines, long considered failures, are hot again

    5:09 p.m. Oct. 1, 2017

    - Emma Court

  6. Beauty and the Bust

    1:18 a.m. June 10, 2017

    - Barron's Online

  7. Advaxis shares up 3.9% premarket

    8:07 a.m. May 30, 2017

    - Ciara Linnane

  8. Advaxis and Bristol-Myers to collaborate on cervical cancer treatment

    7:03 a.m. May 30, 2017

    - Ciara Linnane

  9. Advaxis stock jumps 10% after FDA okays clinical trials for Amgen-partnered cancer drug

    9:31 a.m. March 6, 2017

    - Emma Court

  10. Advaxis stock drops 14% after company says midstage trial was interrupted by clinical hold

    8:13 a.m. Oct. 24, 2016

    - Emma Court

  11. Bull trend intact, latest S&P 500 breakout attempt underway

    12:30 p.m. Aug. 23, 2016

    - Michael Ashbaugh

  12. Bull trend intact, latest S&P 500 breakout attempt underway

    12:08 p.m. Aug. 23, 2016

    - Michael Ashbaugh

  13. Charting the Market

    12:03 a.m. Aug. 6, 2016

    - Barron's Online

  14. 5 stocks to watch

    1:27 p.m. Aug. 3, 2016

    - The Trading Deck

  15. Advaxis stock jumps 28% on Amgen immunotherapy agreement

    8:42 a.m. Aug. 2, 2016

    - Emma Court

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/adxs

Other News on ADXS

  1. 10-Q: ADVAXIS, INC.

    8:34 a.m. March 17, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Advaxis wins shareholder approval for Biosight merger

    9:39 a.m. Dec. 17, 2021

    - Seeking Alpha

  3. 10-Q: ADVAXIS, INC.

    6:06 a.m. Sept. 10, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  4. Advaxis initiates early-stage ADXS-504 prostate cancer study

    8:21 a.m. July 15, 2021

    - Seeking Alpha

  5. OSAT, BSQR, CPOP and AHT among midday movers

    12:59 p.m. July 6, 2021

    - Seeking Alpha

  6. 10-Q: ADVAXIS, INC.

    4:03 p.m. June 14, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  7. IOVA, CAN, ADXS and RETA among midday movers

    12:43 p.m. May 19, 2021

    - Seeking Alpha

  8. Advaxis proposes $20M registered direct offering

    8:47 a.m. April 12, 2021

    - Seeking Alpha

  9. Advaxis to fund earl-stage ADXS-504 study for prostate cancer

    8:43 a.m. April 5, 2021

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/adxs

Press Releases on ADXS

  1. OTC Markets Group Welcomes Advaxis, Inc. to OTCQX

    8:00 a.m. Dec. 23, 2021

    - PR Newswire - PRF

  2. Advaxis Announces Acceptance for Trading on the OTCQX

    5:05 p.m. Dec. 22, 2021

    - GlobeNewswire

  3. Advaxis, Inc. Issues Letter to Stockholders

    9:00 a.m. Nov. 19, 2021

    - GlobeNewswire

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.